A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome

Study participants will receive rozanolixizumab during the dosing periods as pre-defined.

Study participants will receive Placebo during the dosing periods as pre-defined.